Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |